Format

Send to

Choose Destination
Pediatr Infect Dis J. 2011 Jun;30(6):501-5. doi: 10.1097/INF.0b013e31820b583d.

Drug-resistant tuberculosis: pediatric guidelines.

Author information

1
Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.

PMID:
21297522
DOI:
10.1097/INF.0b013e31820b583d
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center